The healthcare sector is experiencing a significant transformation, fueled by technological advancements, evolving patient expectations, and an increasing emphasis on value-based care. The integration of digital health technologies, such as telemedicine, wearable devices, and remote patient monitoring, is revolutionizing how healthcare services are delivered. The rise of artificial intelligence (AI) in diagnostics, predictive analytics, and personalized medicine is enhancing treatment outcomes while reducing operational costs. Additionally, the expansion of biotechnology and genomics is paving the way for breakthroughs in precision medicine, gene therapy, and vaccine development. In response to the global health challenges, there is a significant push toward sustainable healthcare solutions, with a focus on reducing waste and optimizing resource utilization. The adoption of robotic surgeries, 3D-printed implants, and nanotechnology is reshaping patient care, offering minimally invasive and highly effective treatment options. Meanwhile, the growing demand for mental health solutions has emphasized developing innovative therapies and digital tools to address psychological well-being.
Navistrat Analytics provides comprehensive market research reports that delve into these transformative trends, offering actionable insights into the evolving landscape of the healthcare sector. From advancements in digital health to breakthroughs in biotechnology and robotic healthcare, our reports equip businesses with the knowledge to innovate and thrive.
Unlock the future of healthcare with our reports.
The global FemTech market reached USD 31.53 billion in 2025 and is expected to register a revenue CAGR of 17.2% during the forecast period. Growing awareness and focus on women’s health, rising prevalence of women-specific health conditions, increasing adoption of telehealth and virtual care models and rising investment and funding in FemTech startups are expected to drive revenue growth of the market. [...]
Rare cell isolation market size reached USD 1,995.7 Million in 2025 and is expected to register a revenue CAGR of 10.3% during the forecast period. Rare cells are those that exist in small numbers among a much larger population of background cells. Rare cells have a significant role in a variety of applications, including cancer diagnosis and prognosis, prenatal diagnostics, and viral infection diagnosis. Rare cells in blood samples include circulating tumor cells (CTCs), circulating fetal cells, stem cells, and cells infected with a virus or parasite. [...]
Immune repertoire sequencing market size reached USD 343.8 Million in 2025 and is expected to register a revenue CAGR of 9.2% during the forecast period. Immune repertoire sequencing (IR-Seq) uses next-generation sequencing (NGS) to characterize the variety of B-cell receptors (BCRs) and T-cell receptors.1 IR-Seq allows researchers to analyse repertoire diversity and clonality, as well as look into receptor sequences linked to haematological malignancies, autoimmune diseases, and other illnesses. [...]
Companion diagnostics market size reached USD 9.46 Billion in 2025 and is expected to register a revenue CAGR of 10.6% during the forecast period. Companion diagnostics are tests or assays that help identify patients who will benefit the most from a specific treatment or medicine. These tests are frequently used in precision medicine to adapt treatments to individual patients based on unique traits such as genetics, biomarker expression, or other diagnostic criteria. [...]
Implantable drug delivery devices market size reached USD 31.55 Billion in 2025 and is expected to register a revenue CAGR of 8.3% during the forecast period. An implantable drug delivery system (IDDS) is a surgically implanted medical device that delivers medication or therapeutic agents directly to specific tissues or organs in the body, allowing for localized and regulated drug administration. The widespread acceptance of this delivery method could be attributed to the benefits of IDDSs, such as accurate drug distribution to the target tissue to prevent bioavailability or first-pass metabolism issues, which allow for a reduction in active doses. [...]
Neurocognitive assessment and rehabilitation market size reached USD 14.52 Billion in 2025 and is expected to register a revenue CAGR of 9.4% during the forecast period. Neuropsychological examinations are critical in designing successful rehabilitation regimens for patients with neurological disorders. These examinations provide critical insights into how brain function influences thinking, conduct, and emotional well-being. Neuropsychological examinations are typically part of a larger, multidisciplinary strategy that includes neuropsychologists, neurologists, physiotherapists, occupational therapists, speech and language therapists, and the patient's family or caregivers. [...]
Photon counting computed tomography market size reached USD 87.3 million in 2025 and is expected to register a revenue CAGR of 27.7% during the forecast period. Photon-counting computed tomography (PCCT) is a novel sophisticated imaging technique that will revolutionize the traditional clinical use of computed tomography (CT). Photon-counting detectors divide the number of photons and incident X-ray energy spectrum into several energy bins. [...]
AI in endoscopy market size reached USD 1,668.5 million in 2025 and is expected to register a revenue CAGR of 24.8% during the forecast period. AI-based endoscopy technologies may improve the efficacy of endoscopic procedures. AI algorithms could enhance endoscopic operations by automating functions like as image processing and interpretation, saving both time and money. [...]
Genomic cancer panel profiling market size reached USD 8.87 billion in 2024 and is expected to register a revenue CAGR of 11.4% during the forecast period. A laboratory technique called genomic profiling examines the genetic material of cancer cells to find changes and mutations in hundreds of genes. This method assesses the DNA and RNA of tumors using cutting-edge instruments like next-generation sequencing (NGS), offering a comprehensive picture of their genetic landscape. [...]
The spine surgery robotics market size reached USD 325.6 million in 2024 and is expected to register a revenue CAGR of 12.7% during the forecast period. Robotic spine surgical systems convert spine surgery from freehand to highly accurate, cutting-edge robotic methods that require less radiation. It is utilized for operations such as minimally invasive surgery (MIS), scoliosis, and other difficult spinal deformities. Neurosurgeons and spine specialists can reach previously unheard-of precision, efficiency, and safety by using robotics into surgical procedures. [...]
Viral vector and plasmid manufacturing market size reached USD 5.25 billion in 2024 and is expected to register a revenue CAGR of 19.7% during the forecast period. The use of plasmid DNA in the creation of viral vectors for gene therapy is a significant achievement in medical science. Viral vectors, such as retroviral, adenoviral, and lentiviral vectors, are important in gene therapy because of their high transduction efficiency and sustained gene expression. [...]
The microbubbles/ultrasound contrast agents market size reached USD 1,542.6 Million in 2024 and is expected to register a revenue CAGR of 14.4% during the forecast period. In cardiology and radiology, microbubbles are utilized as blood pool agents in contrast ultrasonography imaging. [...]
The exosome diagnostic & therapeutic market size reached USD 82.6 Million in 2024 and is expected to register a revenue CAGR of 46.7% during the forecast period. Exosomes are a type of extracellular vesicle produced by all cells and are found in a variety of bodily fluids. Exosomes serve critical roles in tumour initiation and development, immunological suppression, immune surveillance, metabolic reprogramming, angiogenesis, and macrophage polarization. [...]
The decentralized clinical trials market size reached USD 8.87 billion in 2024 and is expected to register a revenue CAGR of 10.2% during the forecast period. A decentralized clinical trial (DCT) is one in which part or all trial-related activities take place in locations other than standard clinical trial sites. They can provide numerous benefits to pharmaceutical firms, including cost savings, greater patient recruitment and retention, and higher data quality. [...]
The self-amplifying RNA synthesis market size reached USD 107.8 million in 2024 and is expected to register a revenue CAGR of 20.3% during the forecast period. Self-amplifying mRNA, or saRNA, is a synthetic version of mRNA that can replicate itself. Unlike ordinary mRNA, which typically encodes a single protein, saRNA goes one step farther. It contains not only the genetic instructions for a given protein, but also the machinery required for self-replication. [...]